Figure 2:
A. Eleven (91.7%) had any medication adverse effects. B. Six (50.0%) had positive test and four (33.0%) had a return of mild symptoms after nirmatrelvir–ritonavir course. COVID-19, coronavirus disease 2019.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.